ListedSMEPharmaceuticals & DrugsGOLDLINE

Goldline Pharmaceutical IPO

Goldline Pharmaceutical IPO is a sme IPO raising ₹12 Cr at ₹41 – ₹43 a share. It listed on 19 May 2026 and trades at ₹37 today, −13.0% against its issue price of ₹43. It was subscribed 0.00× in total.

Get alerts on this company Company page

₹43

Issue price

₹37

Price now

−13.0%

Since issue price

19 May 2026

Listed on

0.00×Subscribed (final) · all exchanges

No bids yet

populated partly populated we hold nothing here — the tab says why

Terms of the issue

The mechanics of what is being sold. Held for every issue we track.

Price band₹41 – ₹43

Cut-off price₹43

Issue size₹12 Cr

Shares per lot3000

Minimum application₹1,29,000

Minimum quantity6000

Face value₹10

Listing exchangesBSE

ISININE1CLW01015

Bidding hours10:00 – 17:00 IST

Bidding window12 May 2026 – 14 May 2026

SME

What being an SME issue means here. SME issues list on NSE Emerge or BSE SME. They disclose less than mainboard issues, trade far more thinly, and — by regulation — the minimum application is a full lot worth roughly ₹1–1.5 lakh rather than about ₹15,000. That is why the minimum above is so much larger than for a mainboard issue.

Not here yet

Valuation against the issuer's named peers, what the fresh money funds, and the anchor-investor allocation come from reading the prospectus, which we do for current and upcoming issues — historical issues will not gain them.